Literature DB >> 20079722

Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.

Marta Moya1, M José Gómez-Lechón, José V Castell, Ramiro Jover.   

Abstract

Steatosis is the first step in the development of non-alcoholic fatty liver disease (NAFLD). However, the mechanisms involved in its pathogenesis are not fully understood. Many nuclear receptors (NRs) involved in energy homeostasis and biotransformation constitute a network connecting fatty acids, cholesterol and xenobiotic metabolisms; therefore, multiple NRs and their ligands may play a prominent role in liver fat metabolism and accumulation. In this study we have attempted to gain insight into the relevance of the NR superfamily in NAFLD by investigating the steatogenic potential of 76 different NR ligands in fatty acid overloaded human hepatocytes and hepatoma cells. Moreover, we have determined the mRNA expression level of 24 NRs to correlate the steatogenic potential of the ligands with the expression of their associated NRs in the cultured cells. Our results demonstrate that 18% of the examined NR ligands enhanced lipid accumulation in human hepatocytes and/or hepatoma cells. Among them, ligands of PPARgamma (e.g., thiazolidinediones), LXR (paxilline and 24(S),25-epoxycholesterol), PXR (hyperforin), CAR (3alpha,5alpha-androstenol), ERalpha (tamoxifen), FXR (Z-guggulsterone), VDR (25-hydroxyvitamin D3) and particular retinoids and farnesoids showed a significant pro-steatotic effect. The mRNA level of most of the NRs examined was well preserved in human hepatocytes, but HepG2 showed a deranged profile, where many of the receptors had a marginal or negligible level of expression in comparison with the human liver. By comparing the steatogenic effect of NR ligands with the NR expression levels, we conclude that LXR, PXR, RAR and PPARgamma ligands likely induce fat accumulation by a NR-dependent mechanism. Indeed, over-expression of PXR in HepG2 cells enhanced the steatogenic effect of hyperforin and rifampicin. However, the accumulation of fat induced by other ligands did not correlate with the expression of their associated NR. Our results also suggest that human hepatocytes cultured with free fatty acids offer a highly valuable in vitro system to investigate the pathogenesis and therapeutics of the human fatty liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079722     DOI: 10.1016/j.cbi.2010.01.008

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  27 in total

1.  Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.

Authors:  Luis E Gomez-Quiroz; Daekwan Seo; Yun-Han Lee; Mitsuteru Kitade; Timo Gaiser; Matthew Gillen; Seung-Bum Lee; Ma Concepcion Gutierrez-Ruiz; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson; Jens U Marquardt
Journal:  Toxicology       Date:  2016-07-06       Impact factor: 4.221

Review 2.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

3.  CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model.

Authors:  Marta Benet; Agustín Lahoz; Carla Guzmán; José V Castell; Ramiro Jover
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 4.  Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

Authors:  Satyanarayana R Pondugula; Sridhar Mani
Journal:  Cancer Lett       Date:  2012-08-29       Impact factor: 8.679

5.  SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.

Authors:  Linhao Li; Haishan Li; Brandy Garzel; Hui Yang; Tatsuya Sueyoshi; Qing Li; Yan Shu; Junran Zhang; Bingfang Hu; Scott Heyward; Timothy Moeller; Wen Xie; Masahiko Negishi; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2015-01-27       Impact factor: 4.436

6.  Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture.

Authors:  Banrida Wahlang; K Cameron Falkner; Heather B Clair; Laila Al-Eryani; Russell A Prough; J Christopher States; Denise M Coslo; Curtis J Omiecinski; Matthew C Cave
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

7.  Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice.

Authors:  Avery L McIntosh; Barbara P Atshaves; Danilo Landrock; Kerstin K Landrock; Gregory G Martin; Stephen M Storey; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

8.  Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis.

Authors:  Banrida Wahlang; Russell A Prough; K Cameron Falkner; Josiah E Hardesty; Ming Song; Heather B Clair; Barbara J Clark; J Christopher States; Gavin E Arteel; Matthew C Cave
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

9.  Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.

Authors:  Banrida Wahlang; Ming Song; Juliane I Beier; K Cameron Falkner; Laila Al-Eryani; Heather B Clair; Russell A Prough; Tanasa S Osborne; David E Malarkey; J Christopher States; Matthew C Cave
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-03       Impact factor: 4.219

Review 10.  PXR antagonists and implication in drug metabolism.

Authors:  Sridhar Mani; Wei Dou; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.